NTRK fusions are pathognomonic in rare types of cancer, such as the ETV6-NTRK3 fusions in secretory carcinoma of the breast or salivary gland [2,3], congenital mesoblastic nephroma [4], and infantile fibrosarcoma (IFS) [5]. Here, ETV6 is linked to congenital fibrosarcoma.